| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/05/2009 | US7528130 Cytotoxic agents comprising taxanes and their therapeutic use |
| 05/05/2009 | US7528124 1,3-dihydro-2H-indol-2-one derivative |
| 05/05/2009 | US7528116 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis |
| 05/05/2009 | US7528110 Anti-allergic complex molecules |
| 05/05/2009 | US7528093 Using genetic rearrangement in genomic region associated with brain voltage-gated sodium channel to detect convulsive disorder |
| 05/05/2009 | US7527952 Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid (IIMPDH/XMP*/MPA) |
| 05/05/2009 | CA2448281C Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 05/05/2009 | CA2386230C Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy |
| 05/05/2009 | CA2347863C Treatment of disorders of the outer retina |
| 05/05/2009 | CA2322953C Pyridine derivative and pharmaceutical containing the same |
| 05/05/2009 | CA2234980C Cyclopeptide derivatives |
| 05/05/2009 | CA2173338C Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 04/30/2009 | WO2009055021A1 Methods and compositions for treating hepatic diseases |
| 04/30/2009 | WO2009055001A2 Methods of treating aging and methods of screening candidate agents therefor |
| 04/30/2009 | WO2009054537A1 PEPTIDE VACCINE USING MIMIC MOLECULE OF AMYLOID β-PEPTIDE |
| 04/30/2009 | WO2009054504A1 Ligand agent for peroxisome proliferator-activated receptor (ppar) |
| 04/30/2009 | WO2009054483A1 Drug containing salusin-β |
| 04/30/2009 | WO2009054479A1 Spiro-ring compound and use thereof for medical purposes |
| 04/30/2009 | WO2009054471A1 Immune response inducer |
| 04/30/2009 | WO2009054468A1 Azolecarboxamide compound or salt thereof |
| 04/30/2009 | WO2009054463A1 Pharmaceutical composition containing lipophilic il-2 production inhibitor |
| 04/30/2009 | WO2009054454A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
| 04/30/2009 | WO2009054439A1 Pai-1 production inhibitor |
| 04/30/2009 | WO2009054434A1 Amine derivative having npy y5 receptor antagonist activity and use thereof |
| 04/30/2009 | WO2009054423A1 Oxadiazolidinedione compound |
| 04/30/2009 | WO2009054390A1 Thiazolidinedione compound |
| 04/30/2009 | WO2009054361A1 Hair growth promoter |
| 04/30/2009 | WO2009054360A1 Agent for specifically reducing visceral fat |
| 04/30/2009 | WO2009054332A1 Pyridone-substituted-dihydropyrazolopyrimidinone derivative |
| 04/30/2009 | WO2009054150A1 Tetrapyrrole derivative, and use thereof for medical purposes |
| 04/30/2009 | WO2009052970A2 Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors |
| 04/30/2009 | WO2009032885A3 Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis |
| 04/30/2009 | WO2007095497A9 Compositions and methods for prevention and treatment of cachexia |
| 04/30/2009 | WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling |
| 04/30/2009 | US20090111992 Alkyl ether derivatives or salts thereof |
| 04/30/2009 | US20090111862 Compound |
| 04/30/2009 | US20090111802 Cyclocarbamate derivatives as progesterone receptor modulators |
| 04/30/2009 | US20090111737 Novel antibacterial agents |
| 04/30/2009 | US20090111735 Compounds and methods for reducing undesired toxicity of chemotherapeutic agents |
| 04/30/2009 | US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex |
| 04/30/2009 | US20090110724 Compositions and methods for treatment of pain |
| 04/30/2009 | US20090110710 Devices and methods for treating defects in the tissue of a living being |
| 04/30/2009 | US20090110698 Method of determining vaccine compliance |
| 04/30/2009 | US20090110687 Compositions and methods related to tim 3, a th1-specific cell surface molecule |
| 04/30/2009 | US20090110669 Methods for improving cell line activity in immunoisolation devices |
| 04/30/2009 | US20090110656 Skin cooling composition |
| 04/30/2009 | US20090110643 Method of Producing Liposomes Containing Gas Enclosed Therein |
| 04/30/2009 | US20090110637 LMP and Regulation of Tissue Growth |
| 04/30/2009 | US20090110634 Radiolabelled nanoparticles |
| 04/30/2009 | DE102007050574A1 Lozenge, useful e.g. for preventing cold diseases, comprises colostrum having a concentration of immunoglobulins in concentrated form, glycans as adjuvants, sugar alcohols as entraining agent, a tableting agent and flavoring additives |
| 04/30/2009 | CA2704013A1 Spiro-ring compound and use thereof for medical purposes |
| 04/30/2009 | CA2703797A1 Amine derivative having npy y5 receptor antagonist activity and use thereof |
| 04/30/2009 | CA2703793A1 Oxadiazolidinedione compound |
| 04/30/2009 | CA2703494A1 Inhibitor of pai-1 production |
| 04/30/2009 | CA2703489A1 Pyridone-substituted-dihydropyrazolopyrimidinone derivative |
| 04/30/2009 | CA2703350A1 Immune response inducer |
| 04/30/2009 | CA2703106A1 Azolecarboxamide derivatives as trka inhibitors |
| 04/30/2009 | CA2703080A1 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
| 04/29/2009 | EP2053135A1 Bone morphonic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 04/29/2009 | EP2053061A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 04/29/2009 | EP2053041A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease |
| 04/29/2009 | EP2053033A1 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
| 04/29/2009 | EP2052742A1 Treatment of B-cell associated diseases such as malignancies and autoimmune diseases using a cold anti-CD20 antibody/radiolabeled anti-CD22 antibody combination |
| 04/29/2009 | EP2052738A1 THERAPEUTIC AGENT FOR ACCELERATION OF SPINAL NERVE REPAIR COMPRISING GHRELIN, DERIVATIVE THEREOF OR SUBSTANCE CAPABLE OF ACTING ON GHS-R1a AS ACTIVE INGREDIENT |
| 04/29/2009 | EP2052725A2 Use of lanthanum compounds for the treatment of bone diseases |
| 04/29/2009 | EP2052720A2 Use of at least one hydroxylamine compound for the treatment of eye disease |
| 04/29/2009 | EP2051713A1 Prevention and treatment of microbial infection |
| 04/29/2009 | EP2051712A2 Modulators of muscarinic receptors |
| 04/29/2009 | EP1765311A4 Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids |
| 04/29/2009 | EP1539764B1 Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists. |
| 04/29/2009 | EP1511472B1 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 04/29/2009 | EP1485347B1 Hif hydroxylase inhibitors for use in the treatment of anaemia |
| 04/29/2009 | EP1461319B1 Quinoline derivatives, synthesis method, and medicines containing said derivatives |
| 04/29/2009 | EP1454136B1 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/29/2009 | EP1446125B1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 04/29/2009 | EP1438288B1 Substituted thioacetamides |
| 04/29/2009 | EP1383540B1 Methods and pharmaceutical compositions for healing wounds |
| 04/29/2009 | EP1372685B1 Use of extracts of the plant litchi chinensis sonn. |
| 04/29/2009 | EP1345910B1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof |
| 04/29/2009 | EP1343807B1 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 04/29/2009 | EP1265927B1 Crystal |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | EP1066286B1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 04/29/2009 | CN101420946A Tamsulosin-containing percutaneous absorption type preparation |
| 04/29/2009 | CN101418270A High density culture method of lactobacillus casei Zhang, method for preparing freeze-dried powder by using the same and obtained freeze-dried powder and uses thereof |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/29/2009 | CN101417041A Traditional Chinese medicine preparation capable of preventing and treating coronary heart disease angina, heat-stroke abdomen pain, heart and abdomen pain |
| 04/29/2009 | CN101417006A Preparation method of animal medicine capable of increasing animal immunity and reducing stress reaction |
| 04/29/2009 | CN101416969A Preparation method of ecdysterone cream capable of promoting wound healing |
| 04/29/2009 | CN101416832A Traditional Chinese medicine health-care pillow |
| 04/29/2009 | CN101416831A Traditional Chinese medicine pillow |
| 04/29/2009 | CN100482795C IREN protein, its preparation and use |
| 04/29/2009 | CN100482688C Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 04/29/2009 | CN100482686C Treatment for diabetes |
| 04/29/2009 | CN100482684C Cytokine protein family |
| 04/29/2009 | CN100482665C Pyrazolo 1,5-a pyrimidine derivatives |
| 04/29/2009 | CN100482646C Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics |
| 04/29/2009 | CN100482638C N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 04/29/2009 | CN100482635C Noval compounds, their use and preparation |